RBC
PFE icon

Ronald Blue & Co’s Pfizer PFE Stock Holding History

Ronald Blue & Co’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$994K Sell
31,189
-412
-1% -$13K 0.03% 74
2017
Q1 		$1.02M Buy
31,601
+1,797
+6% +$56.7K 0.04% 76
2016
Q4 		$919K Sell
29,804
-6,620
-18% -$202K 0.04% 84
2016
Q3 		$1.17M Sell
36,424
-3,140
-8% -$105K 0.05% 60
2016
Q2 		$1.32M Sell
39,564
-5,340
-12% -$170K 0.06% 55
2016
Q1 		$1.26M Buy
44,904
+5,472
+14% +$156K 0.07% 51
2015
Q4 		$1.21M Sell
39,432
-21,879
-36% -$688K 0.06% 53
2015
Q3 		$1.83M Sell
61,311
-20,368
-25% -$653K 0.1% 43
2015
Q2 		$2.6M Sell
81,679
-1,685
-2% -$54.9K 0.12% 28
2015
Q1 		$2.75M Sell
83,364
-20,531
-20% -$653K 0.13% 27
2014
Q4 		$3.07M Buy
103,895
+2,626
+3% +$75.3K 0.15% 26
2014
Q3 		$2.84M Sell
101,269
-481
-0.5% -$13.5K 0.18% 24
2014
Q2 		$2.87M Buy
101,750
+9,839
+11% +$280K 0.18% 24
2014
Q1 		$2.8M Buy
91,911
+1,027
+1% +$30.6K 0.2% 25
2013
Q4 		$2.64M Sell
90,884
-1,462
-2% -$42.5K 0.2% 28
2013
Q3 		$2.52M Buy
92,346
+47,575
+106% +$1.29M 0.21% 27
2013
Q2 		$1.19M Buy
+44,771
New +$1.24M 0.1% 34

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ronald Blue & Co's PFE Position: Q2 2017 in Review

Ronald Blue & Co reduced its Pfizer (PFE) stake by 1.3% in Q2 2017, selling an estimated $13K and leaving 31,189 shares worth $994K. The position accounts for 0.03% of the portfolio, ranked #74.

Ronald Blue & Co first reported a position in PFE in Q2 2013 and has held it in 17 quarters since. The position peaked at $3.07M in Q4 2014. 2,050 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

  • Ronald Blue & Co held 31,189 shares of Pfizer worth $994K as of Q2 2017.
  • Ronald Blue & Co sold 412 Pfizer shares in Q2 2017, an estimated $13K.
  • Pfizer made up 0.03% of Ronald Blue & Co's portfolio in Q2 2017, its #74 holding.
  • Ronald Blue & Co first reported a position in Pfizer in Q2 2013 and has held it in 17 quarters since.
  • Ronald Blue & Co's Pfizer position peaked at $3.07M in Q4 2014.
  • 2,050 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Ronald Blue & Co's 13F filing for Q2 2017, filed 28 Jul 2017.